Article
[Glioblastoma].
Revue medicale de Liege - 1 May 2021
Martin D H, Bianchi E, Ben Mustapha S, Frères P
Abstract excerpt
Glioblastoma is the most common primary malignant brain tumor. Despite treatments combining excisional surgery, chemotherapy, and radiotherapy, overall survival remains low and the incidence of tumor recurrence remains high. Advances in the understanding of the disease, particularly its molecular biology and the mechanisms of action of systemic and radiotherapeutic treatments, as well as the development of...
Topics
- Biomarkers, Tumor
- Brain Neoplasms
- DNA Methylation
- Glioblastoma
- Humans
- Mutation
- Neoplasm Recurrence, Local
- Prognosis
